Showing results (2921-2930 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|November 29, 2002
Quality of life in patients with epilepsy and impact of treatmentsPatrizia BertoPharmacoeconomics|November 30, 2002
Meeting the challenges to European healthcare: lessons learned from the 'Stockholm Revolution'Johan HjertqvistPharmacoeconomics|November 30, 2002
Balancing the cost and value of medications: the dilemma facing cliniciansJerry AvornPharmacoeconomics|November 30, 2002
The Agrenska centre: a socioeconomic case study of rare diseasesAnders OlausonPharmacoeconomics|November 30, 2002
The role of marketing in pharmaceutical research and developmentJohn E CalfeePharmacoeconomics|July 3, 2002
A model to estimate the cost benefit of an occupational vaccination programme for influenza with Influvac in the UKRoben Das Gupta, Julian F GuestPharmacoeconomics|April 8, 2003
Outpatient therapy for febrile neutropenia: clinical and economic implicationsFausto de LallaPharmacoeconomics|March 22, 2003
A model to assess the cost effectiveness of statins in achieving the UK National Service Framework target cholesterol levelsKoo Wilson, John Marriott, Stephen Fuller, et al.Pharmacoeconomics|March 27, 2013
Optimal global value of information trials: better aligning manufacturer and decision maker interests and enabling feasible risk sharingSimon Eckermann, Andrew R WillanPharmacoeconomics|March 21, 2013
The cost effectiveness of pharmacological treatments for generalized anxiety disorderIfigeneia Mavranezouli, Nick Meader, John Cape, et al.Pageof 336